Mechanistically, JWA promotes the degradation of specificity protein 1 (SP1) through the ubiquitin-proteasome pathway and then inhibits the expression of its downstream pro-angiogenic factor MMP2, ultimately inhibiting the angiogenesis of gastric cancer [17]. The gene discussed is ARL6IP5; the disease is gastric cancer.